Royalty Pharma (RPRXN) Q4 2025 Earnings Report
MX:RPRXN Q4 2025 EPS Results
- Actual EPS
- MXN 27.24
- Consensus EPS
- MXN 23.89
- Beat/Miss
- Beat by +MXN 3.34
- One Year Ago EPS
- MXN 21.39
MX:RPRXN Q4 2025 Revenue Results
- Actual Revenue
- MXN 11.56B
- Expected Revenue
- MXN 14.99B
- Beat/Miss
- Missed by -MXN 3.44B
- YoY Revenue Growth
- +4.71%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 02/11/2026
- Time
- Before Open
- Conference Call
- Wednesday, February 11, 2026
MX:RPRXN Upcoming Earnings
Royalty Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
MX:RPRXN Q4 2025 Earnings Call
0:00 / 0:00
Q4 2025 Earnings Slide Deck
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RPRXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 21.94- | 21.8 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 23.6524.55 | 21.2 | 15.78% (+3.34) | |
| May 06, 2026 | 2026 (Q1) | 22.5624.08 | 13.92 | 73.03% (+10.16) | |
| Feb 11, 2026 | 2025 (Q4) | 23.8927.24 | 21.39 | 27.37% (+5.85) | |
| Nov 05, 2025 | 2025 (Q3) | 18.4721.80 | 17.04 | 27.92% (+4.76) | |
| Aug 06, 2025 | 2025 (Q2) | 19.1821.20 | 17.86 | 18.73% (+3.34) | |
| May 08, 2025 | 2025 (Q1) | 17.7113.92 | 18.17 | -23.42% (-4.26) | |
| Feb 11, 2025 | 2024 (Q4) | 19.6021.39 | 21.35 | 0.17% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | 17.2217.04 | 14.66 | 16.22% (+2.38) | |
| Aug 08, 2024 | 2024 (Q2) | 17.9317.86 | 15.7 | 13.73% (+2.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
